[HTML][HTML] Treatment strategies for GLILD in common variable immunodeficiency: a systematic review

OAC Lamers, BM Smits, HL Leavis, GJ de Bree… - Frontiers in …, 2021 - frontiersin.org
Introduction Besides recurrent infections, a proportion of patients with Common Variable
Immunodeficiency Disorders (CVID) may suffer from immune dysregulation such as …

[HTML][HTML] Rituximab Monotherapy is effective as first-line treatment for granulomatous lymphocytic interstitial lung disease (GLILD) in CVID patients

G Tessarin, M Baronio, L Gazzurelli, S Rossi… - Journal of Clinical …, 2023 - Springer
Granulomatous lymphocytic interstitial lung disease (GLILD) represents a fatal immune
dysregulatory complication in common variable immunodeficiency (CVID). Evidence-based …

Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency

JW Verbsky, MK Hintermeyer, PM Simpson… - Journal of Allergy and …, 2021 - Elsevier
Background Granulomatous and lymphocytic interstitial lung disease (GLILD) is a life-
threatening complication in patients with common variable immunodeficiency (CVID), but the …

[HTML][HTML] Managing granulomatous–lymphocytic interstitial lung disease in common variable immunodeficiency disorders: e-GLILDnet international clinicians survey

AAJM van de Ven, TM Alfaro, A Robinson… - Frontiers in …, 2020 - frontiersin.org
Background Granulomatous–lymphocytic interstitial lung disease (GLILD) is a rare,
potentially severe pulmonary complication of common variable immunodeficiency disorders …

Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable …

NM Chase, JW Verbsky, MK Hintermeyer… - Journal of clinical …, 2013 - Springer
Purpose A subset of patients with common variable immunodeficiency (CVID) develops
granulomatous and lymphocytic interstitial lung disease (GLILD), a restrictive lung disease …

Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)

JH Park, AI Levinson - Clinical Immunology, 2010 - Elsevier
Infectious complications of the lung occur quite frequently in patients with common variable
immunodeficiency (CVID), a clinical syndrome that represents a primary immunodeficiency …

Rituximab monotherapy for common variable immune deficiency-associated granulomatous-lymphocytic interstitial lung disease

J Ng, K Wright, M Alvarez, GM Hunninghake… - Chest, 2019 - Elsevier
Patients with common variable immunodeficiency (CVID) can develop granulomatous-
lymphocytic interstitial lung disease (GLILD), which is associated with increased morbidity …

[HTML][HTML] Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from …

F Cinetto, R Scarpa, M Carrabba, D Firinu… - Frontiers in …, 2021 - frontiersin.org
Background: Granulomatous and Lymphocytic Interstitial Lung Diseases (GLILD) is a severe
non-infectious complication of Common Variable Immunodeficiency (CVID), often …

[HTML][HTML] Treatment-responsive granulomatous-lymphocytic interstitial lung disease in a pediatric case of common variable immunodeficiency

R Tillman, RP Guillerman, T Trojan… - Frontiers in …, 2019 - frontiersin.org
Granulomatous-Lymphocytic Interstitial Lung disease (GLILD) is a granulomatous and
lymphoproliferative condition occurring in~ 25% of Common Variable Immunodeficiency …

Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease

A Mannina, JH Chung, JJ Swigris… - Annals of the …, 2016 - atsjournals.org
Rationale: Granulomatous-lymphocytic interstitial lung disease (GLILD) has emerged as a
major cause of morbidity in patients with common variable immunodeficiency (CVID). While …